SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

Correspondence Activity Detail

INNOCAN PHARMA Corp (INNPF) (CIK 0001889791) (INNPF)
Activity window: Oct. 25, 2025 to Oct. 24, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
0.5 / 10
Correspondence-letter component
0.0
AI sentiment component
0.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jan. 27, 2026. These dates describe different events.

Correspondence Filings
0
Keyword Matches
0
Latest Activity
Jan. 27, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jan. 27, 2026 CORRESP Neutral/Informational Moderate In a correspondence dated January 27, 2026, ThinkEquity LLC, representing the underwriters, has requested the U.S. Securities and Exchange Commission to accelerate the effective d… Read Filing EDGAR
Jan. 27, 2026 CORRESP Neutral/Informational Moderate Innocan Pharma Corporation has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement No. 333-288899. The company aims for the stat… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.